Air Products & Chemicals, Inc. vs Canopy Growth Corp — how do they compare? Air Products & Chemicals, Inc. trades at $302.33 (market cap $66.70B), while Canopy Growth Corp trades at $0.97 (market cap $407.38M). The key difference: Air Products & Chemicals, Inc. is far larger — about 163.7× Canopy Growth Corp's market cap, and Air Products & Chemicals, Inc. pays a 2.42% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| APD | CGC | |
|---|---|---|
Market Cap | $66.70B | $407.38M |
Sector | Basic Materials | Health |
52-Week High | $314.19 | $1.92 |
52-Week Low | $230.42 | $0.86 |
Enterprise Value | $84.11B | $346.82M |
Dividend Yield | 2.42% | — |
Signals from Pluang's Aura AI — not financial advice
APD trades at $299.53, up 1.24% today, with a bullish technical signal from moving averages and strong analyst support. Recent earnings beats and strategic project exits, like the Louisiana Clean Energy Complex, have boosted investor confidence. The company maintains solid profitability margins but faces pressure from a negative net income in 2025 due to a pre-tax charge. Cash flow trends show volatility, with significant investing outflows for growth initiatives.
The outlook is positive with a consensus price target of $324.89, implying ~8% upside. Risks include high debt levels, execution on new projects, and macroeconomic sensitivity. Long-term growth is supported by renewable energy investments, but near-term profitability recovery is key for sustained gains.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Since its founding in 1940, Air Products has become one of the leading industrial gas suppliers globally, with operations in 50 countries and 19,000 employees. The company is the largest supplier of hydrogen and helium in the world. It has a unique portfolio serving customers in a number of industries, including chemicals, energy, healthcare, metals, and electronics. Air Products generated $10.3 billion in revenue in fiscal 2021.
Read more on APD →Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →